Department of Endocrinology and Neuroendocrine Tumours, Department of Pathophysiology and Endocrinology, Medical University of Silesia, Katowice, Poland.
Department of Endocrinology and Neuroendocrine Tumours, Medical University of Silesia, Katowice, Poland.
Endokrynol Pol. 2022;73(3):491-548. doi: 10.5603/EP.a2022.0050.
In this paper, we present the current guidelines for the diagnostics and management of pancreatic neuroendocrine neoplasms (PanNENs) developed by Polish experts providing care for these patients in everyday clinical practice. In oncological diagnostics, in addition to biochemical tests, molecular identification with the use of NETest liquid biopsy and circulating microRNAs is gaining importance. Both anatomical and functional examinations (including new radiopharmaceuticals) are used in imaging diagnostics. Histopathological diagnosis along with immunohistochemical examination still constitute the basis for therapeutic decisions. Whenever possible, surgical procedure is the treatment of choice. Pharmacological management including biotherapy, radioisotope therapy, targeted molecular therapy and chemotherapy are important methods of systemic therapy. Treatment of PanNENs requires a multidisciplinary team of specialists in the field of neuroendocrine neoplasms.
在本文中,我们呈现了由波兰专家制定的关于胰腺神经内分泌肿瘤(PanNENs)的诊断和管理的当前指南,这些专家在日常临床实践中为这些患者提供护理。在肿瘤学诊断中,除了生化测试外,使用 NETest 液体活检和循环 microRNAs 的分子鉴定也越来越重要。在影像学诊断中,既使用解剖学检查,也使用功能检查(包括新的放射性药物)。组织病理学诊断加上免疫组织化学检查仍然是治疗决策的基础。只要有可能,手术就是首选治疗方法。包括生物疗法、放射性同位素治疗、靶向分子治疗和化疗在内的药物治疗是系统治疗的重要方法。PanNENs 的治疗需要一个多学科的神经内分泌肿瘤专家团队。